Argus raised Moderna's target price from $140 to $150 and maintained a "buy" rating on June 21st at Gelunhui.
Argus上调Moderna目标价至150美元
Argus raised the target price of Moderna to $150.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.